Mid-Stage Win for Novel Depression Agent; 'Floordrobe' Disorder; CIA Mind Control

(MedPage Today) -- In the phase II SAVITRI study, once-daily treatment with an investigational, AMPA positive allosteric modulator (NBI-1065845) significantly reduced depression scores by day 28 in people with major depressive disorder who failed...

Source: MedPage Today Psychiatry - April 24, 2024 Category: Psychiatry Source Type: news